这篇综述通过结构虚拟筛选从PubChem数据库中鉴定出两种新型醛糖还原酶（ALDR）抑制剂（CID:45110135和CID:58643777），其结合亲和力（-11.8和-11.5 kcal·mol-1）优于现有药物Epalrestat（-8.6 kcal·mol-1）。经分子对接、ADMET筛选及500 ns分子动力学（MD）模拟验证，候选化合物 ...

本研究针对Epalrestat（醛糖还原酶抑制剂）放大生产中出现的新型杂质（4-甲基-5-苯基-2-噻吩甲酸）开展系统研究，通过HRMS/NMR ...

Diabetic neuropathy is associated with elevated aldose reductase activity. Any agent that inhibits this enzyme might, therefore, provide an effective treatment for this common complication of diabetes ...

Diabetic neuropathy is nerve damage that is caused by diabetes. Over time, high blood glucose levels, also called blood sugar, and high levels of fats, such as triglycerides, in the blood from ...

Review the side-effects of Epalrestat as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Alfa Chemistry, a leading pharmaceutical supplier, has recently announced the addition of three new APIs to its full-ranged product catalog, i.e., tofacitinib citrate, tamoxifen citrate, and ...

Details concerning the Epalrestat medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.

Compared to a control (left), epalrestat treatment (right) reduces the number of metastatic tumors (arrowheads) in the lungs of mice injected with human basal-like breast cancer cells. Disclaimer: ...